News and Opinions - World Stem Cell Summit

Providers Walgreens expands specialty pharmacy business to gene and cell therapy services

by admin | Apr 29, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Heather Landi – Fierce Healthcare – Walgreens is expanding its specialty pharmacy services to offer gene and cell therapy services, supported by a dedicated 18,000-square-foot center in Pittsburgh, the company announced Thursday. The service is part of...

Genetically engineering a treatment for incurable brain tumors

by admin | Apr 24, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Steve Martin – Purdue University – WEST LAFAYETTE, Ind. — Purdue University researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time...

Stem Cells for Species Conservation – ISSCR Webinar celebrating Earth Day 2024

by admin | Apr 22, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By – ISSCR – The international Society for Stem Cell Research will host a free webinar celebrating Earth Day April 22, 2024 Program Description: Celebrate Earth Day by diving into the science of conservation, where the potential of stem cells is harnessed...

Micro-patterning-a new system to induce alveolar and airway epithelial cells

by admin | Apr 19, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By CiRA – Kyoto University – In a recent study, Professor Shimpei Gotoh (Department of Clinical Application) and Junior Associate Professor Kazuo Takayama (Department of Cell Growth and Differentiation) teamed up to construct a novel in vitro culture...

First-in-Human Phase 1/2a Clinical Trial of Autologous Neuronal Cell Replacement Therapy for Parkinson’s Disease

Clinical Trial for Parkinson’s Disease – First-in-Human Phase 1/2a Autologous Neuronal Cell Replacement Therapy

by admin | Apr 18, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Aspen Neuroscience SAN DIEGO, April 17, 2024 /PRNewswire/ — Aspen Neuroscience, Inc. announced that the first patient has been dosed in the ASPIRO trial, a Phase 1/2a open label clinical trial to assess safety and tolerability of ANPD001, an autologous,...

Accelerated aging may be a cause of increased cancers in people under 55

by admin | Apr 17, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Joseph Choi – The Hill – An increase in cancers among people 55 years old and younger may be related to accelerated aging in recent generations, according to a study presented at a conference earlier this month. Experts say years of research support...